Abstract: This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.

Abstract: The invention relates to an elevator comprising a hoistway; an elevator car vertically movable in the hoistway; a plurality of ropes connected to the car; a rotatable traction member comprising a circumferential traction surface area for each of the several ropes; each rope being arranged to pass around the rotatable traction member resting against a circumferential traction surface area of the traction member; drive machinery for controlling rotation of the rotatable traction member. The elevator comprises means for detecting displacement of each of the ropes over a first limit position of the rope in the first axial direction of the rotatable traction member, and over a second limit position of the rope in the second axial direction of the traction member; and in that displacement of one or more of said ropes in axial direction of the rotatable traction member over the first or second limit position is arranged to trigger the drive machinery to stop the rotation of the rotatable traction member.

Abstract: This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.

Abstract: This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.

Abstract: The invention relates to an elevator comprising a hoistway; an elevator car vertically movable in the hoistway; a plurality of ropes connected to the car; a rotatable traction member comprising a circumferential traction surface area for each of the several ropes; each rope being arranged to pass around the rotatable traction member resting against a circumferential traction surface area of the traction member; drive machinery for controlling rotation of the rotatable traction member. The elevator comprises means for detecting displacement of each of the ropes over a first limit position of the rope in the first axial direction of the rotatable traction member, and over a second limit position of the rope in the second axial direction of the traction member; and in that displacement of one or more of said ropes in axial direction of the rotatable traction member over the first or second limit position is arranged to trigger the drive machinery to stop the rotation of the rotatable traction member.

Abstract: This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.

Abstract: This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.

Abstract: This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.

Abstract: This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.

Abstract: This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.

Abstract: The invention relates to a process for producing a product containing flax proteins and flax mucilage, in which process linseeds are cold and/or hot pressed and, if desired, further extracted with a suitable solvent for separating the linseed oil, the resulting pressed and crushed flax is alkali extracted and the insoluble fibre is separated, the alkaline extract is precipitated with an acid and a lower alkanol for producing a precipitate containing proteins and mucilage, the lower alkanol is separated from the precipitate and the resulting preparation is used as such or it is dried and possibly mixed with suitable adjuvants. The invention also relates to a flax protein product containing flax mucilage and its use in food processing, especially in baking.

Abstract: This invention relates to a liquid or semisolid oral drug formulation comprising a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with a pharmaceutically acceptable carrier.